European agency approves swine flu vaccines for licensing
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3992 (Published 29 September 2009) Cite this as: BMJ 2009;339:b3992- Sophie Cook
- 1BMJ
Two swine flu vaccines, including one of those to be used in the United Kingdom’s vaccination programme, were approved for licensing by the European Medicines Agency on 25 September.
The agency’s committee for medicinal products for human use expedited the assessment of the vaccines—Focetria from Novartis and Pandemrix from GlaxoSmithKline—and recommended that they be granted a licence by the European Commission.
The Department of Health for England said, “This is a positive step towards getting full licences for vaccines to protect the public. The European Commission must now consider the recommendations, and we hope for its decision as quickly …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.